HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors (clinicaltrials.gov) - Aug 28, 2023 - P1/2 | N=2000 | Suspended | Sponsor: Alaunos Therapeutics | Recruiting ➔ Suspended
IO biomarker • Trial suspension • Biliary Cancer • Cholangiocarcinoma • Colorectal Cancer • Endometrial Cancer • Gastrointestinal Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Ovarian Cancer • Pancreatic Cancer
|